336 related articles for article (PubMed ID: 15523365)
1. Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis.
Vázquez-López F; Marghoob AA
J Am Acad Dermatol; 2004 Nov; 51(5):811-3. PubMed ID: 15523365
[TBL] [Abstract][Full Text] [Related]
2. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
3. Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
[TBL] [Abstract][Full Text] [Related]
4. Combination topical therapy for the treatment of psoriasis.
Del Rosso Do JQ
J Drugs Dermatol; 2006 Mar; 5(3):232-4. PubMed ID: 16573255
[TBL] [Abstract][Full Text] [Related]
5. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.
Katoh N; Kishimoto S
Eur J Dermatol; 2003; 13(4):382-4. PubMed ID: 12948920
[TBL] [Abstract][Full Text] [Related]
6. Femoral head osteonecrosis after long-term topical corticosteroid treatment in a psoriasis patient.
Takahashi H; Tsuji H; Honma M; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2012 Oct; 39(10):887-8. PubMed ID: 22300106
[No Abstract] [Full Text] [Related]
7. Topical antipsoriatics.
Smith KC; Lebwohl M
Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842
[TBL] [Abstract][Full Text] [Related]
8. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
Lebwohl M; Colón LE
Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
[TBL] [Abstract][Full Text] [Related]
10. Microcirculatory modifications of psoriatic lesions during topical therapy.
Rosina P; Giovannini A; Gisondi P; Girolomoni G
Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121
[TBL] [Abstract][Full Text] [Related]
11. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
12. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
Brodell RT; Bruce S; Hudson CP; Weiss JS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
[TBL] [Abstract][Full Text] [Related]
13. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream.
Rigopoulos D; Ioannides D; Prastitis N; Katsambas A
Acta Derm Venereol; 2002; 82(2):140. PubMed ID: 12125946
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
15. Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years.
Zampetti A; Barone A; Antuzzi D; Amerio P; Tulli A; Feliciani C; Amerio P
J Dermatolog Treat; 2008; 19(3):134-40. PubMed ID: 18569269
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
17. A case of generalized pustular psoriasis treated with topical tacrolimus.
Nagao K; Ishiko A; Yokoyama T; Tanikawa A; Amagai M
Arch Dermatol; 2003 Sep; 139(9):1219. PubMed ID: 12975175
[No Abstract] [Full Text] [Related]
18. Clobetasol propionate for psoriasis: are ointments really more potent?
Warino L; Balkrishnan R; Feldman SR
J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome caused by topical steroid therapy for psoriasis.
Abma EM; Blanken R; De Heide LJ
Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
[TBL] [Abstract][Full Text] [Related]
20. Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
Lebwohl MG
Cutis; 2007 Jan; 79(1 Suppl 2):3-4. PubMed ID: 17367039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
